Cannara Biotech (LOVFF, $0.56) was a top loser over the last three months, falling -2 to $0.56 per share. A.I.dvisor analyzed 277 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 4, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.